These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3703261)

  • 1. The treatment of passively transferred experimental myasthenia with anti-idiotypic antibodies.
    Souroujon MC; Pachner AR; Fuchs S
    Neurology; 1986 May; 36(5):622-5. PubMed ID: 3703261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiotypes and anti-idiotypes in experimental autoimmune myasthenia gravis.
    Souroujon MC; Fuchs S
    Ann N Y Acad Sci; 1986; 475():81-93. PubMed ID: 3491567
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
    Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
    J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental models of myasthenia gravis: lessons in autoimmunity and progress toward better forms of treatment.
    Pachner AR
    Yale J Biol Med; 1987; 60(2):169-77. PubMed ID: 3495075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new model of experimental auto-immune myasthenia gravis.
    Souan ML; Geffard M
    J Neuroimmunol; 1985 Oct; 9(6):327-38. PubMed ID: 2413069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiidiotypic antibodies in the regulation of experimental autoimmune myasthenia gravis.
    Souroujon MC; Fuchs S
    Ann N Y Acad Sci; 1987; 505():676-82. PubMed ID: 3500670
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of experimental myasthenia with autologous idiotypes linked to muramyl dipeptide.
    Valderrama R; Eggers AE; Moomjy M; Kao PN; Michl J
    Clin Exp Immunol; 1988 Jul; 73(1):123-7. PubMed ID: 3168327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal anti-acetylcholine receptor antibodies with differing capacities to induce experimental autoimmune myasthenia gravis.
    Gomez CM; Richman DP
    J Immunol; 1985 Jul; 135(1):234-41. PubMed ID: 3873489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune regulation of experimental myasthenia.
    Fuchs S; Bartfeld D; Eshhar Z; Feingold C; Mochly-Rosen D; Novick D; Schwartz M; Tarrab-Hazdai R
    J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):634-43. PubMed ID: 7400824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The auto-anti-idiotypic route to antireceptor antibodies.
    Erlanger BF; Cleveland WL; Wassermann NH; Ku HH; Hill BL; Wan KK; Sarangarajan R; Penn AS
    Ann N Y Acad Sci; 1986; 475():219-26. PubMed ID: 3491562
    [No Abstract]   [Full Text] [Related]  

  • 11. Passively transferred experimental autoimmune myasthenia gravis. Sequential and quantitative study of the motor end-plate fine structure and ultrastructural localization of immune complexes (IgG and C3), and of the acetylcholine receptor.
    Engel AG; Sakakibara H; Sahashi K; Lindstrom JM; Lambert EH; Lennon VA
    Neurology; 1979 Feb; 29(2):179-88. PubMed ID: 571062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological similarities between an experimental autoimmune myasthenia gravis model and human myasthenia gravis.
    Souan ML; Geffard M
    Neurosci Lett; 1986 Aug; 68(3):282-7. PubMed ID: 2427976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of experimental autoimmune myasthenia gravis by a monoclonal antibody to a complementary peptide for the main immunogenic region of the acetylcholine receptors.
    Araga S; Galin FS; Kishimoto M; Adachi A; Blalock JB
    J Immunol; 1996 Jul; 157(1):386-92. PubMed ID: 8683141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-acetylcholine receptor antibody related idiotypes in myasthenia gravis.
    Lefvert AK
    J Autoimmun; 1988 Feb; 1(1):63-72. PubMed ID: 3267109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of development of experimental autoimmune myasthenia gravis with isogeneic monoclonal anti-idiotopic antibody.
    Agius MA; Richman DP
    J Immunol; 1986 Oct; 137(7):2195-8. PubMed ID: 3489757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits.
    Levi G; Tarrab-Hazdai R; Teichberg VI
    Eur J Immunol; 1983 Jun; 13(6):500-7. PubMed ID: 6861875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human x human hybridomas from patients with myasthenia gravis: possible tools for idiotypic therapy for myasthenia.
    Blair DA; Mihovilovic M; Agius MA; Fairclough RH; Richman DP
    Ann N Y Acad Sci; 1987; 505():155-67. PubMed ID: 3500665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive transfer of experimental myasthenia gravis via antigenic modulation of acetylcholine receptor.
    Loutrari H; Kokla A; Tzartos SJ
    Eur J Immunol; 1992 Sep; 22(9):2449-52. PubMed ID: 1516631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-idiotypic antibodies to anti-acetylcholine receptor antibody: characterization by ELISA and immunoprecipitation assays.
    Pachner AR; Sourojon M; Fuchs S
    J Neuroimmunol; 1986 Sep; 12(3):205-14. PubMed ID: 3488332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytophilic antibodies in experimental autoimmune myasthenia gravis.
    Martinez RD; Tarrab-Hazdai R; Aharonov A; Fuchs S
    J Immunol; 1977 Jan; 118(1):17-20. PubMed ID: 830746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.